Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award

Contributed by: Business Wire

Logo

Business Wire logo

Images

Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award
Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award
Business Wire embedded0

Tags

Medical Supplies
Consumer Electronics
Technology
IOT (Internet of Things)
Health
Pharmaceutical
Health Technology
Medical Devices
Apps/Applications
Mobile/Wireless
Hardware
Sempresto, Inc.

More Like This

De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts

Kindeva Drug Delivery awarded up to $129 million to supply DuoDote® autoinjectors to the Strategic National Stockpile

PR Newswire associated0

Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market

PR Newswire associated0

Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag

Enhancing National Preparedness: Rafa Laboratories Partners with BARDA to Advance the Development of a new design for Rafa's Pediatric Atropine Autoinjectors

New Needle-Free Treatment Option for Life-Threatening Anaphylaxis, EURneffy®, Now Available in the UK

PR Newswire associated0

Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with New Concentration

ACCESSWIRE logo

mymediset LiveSync: mymediset and Terso Solutions Announce a New Partnership to Deliver a Revolutionary Supply Chain Platform for Live Consignment Tracking and Automation

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us